Medifocus Guidebook on Myelodysplastic Syndromes

A Comprehensive Patient Guide to Symptoms, Treatment, Research, and Support
 

 
Updated: July 22, 2016
145 Pages

 
 

What is Myelodysplastic Syndromes?

Myelodysplastic syndromes (MDS) represent a group of myeloid (bone marrow) stem cell disorders that gradually affect the ability of a person's bone marrow to produce normal red blood cells, white blood cells, and platelets.

Bone marrow is a semi-liquid tissue that is inside many bones such as the backbones, shoulder blades, ribs, pelvis, and stomach. The hematopoietic (blood-forming) stem cells in the bone marrow are responsible for producing and forming new blood cells. Erythrocytes, or mature red blood cells, help transport oxygen. White blood cells, (leukocytes) are one of the most critical elements of the circulatory system because they help protect the body against infections caused by foreign microorganisms such as bacteria and viruses. Platelets are the smallest cells in the blood and are formed in the red bone marrow. They help control bleeding and bruising.

People with myelodysplastic syndromes have a risk of the disease progressing to acute myeloid leukemia (AML), which is a bone marrow malignancy. Some studies suggest that AML is a natural progression of MDS and not a separate disease. In some people, MDS may gradually progress over a period of many years while in others it progresses rapidly to AML.

The risk of myelodysplastic syndromes increases with age as the disease commonly affects older people between the ages of 58 and 75. It is estimated that MDS affects 15 to 50 people per 100,000 Americans who are over the age of 70. Up to 20,000 new cases of myelodysplastic syndromes are diagnosed each year. However, since there are no actual registries listing the incidence of myelodysplastic syndromes, some researchers estimate that the numbers may actually be much higher. For example, anemia in older individuals may be ascribed to "old age" without consideration of the possibility of myelodysplastic syndromes.

The incidence of myelodysplastic syndromes in children is only 5% to 7% of all pediatric hematologic malignancies. It has been reported that up to 17% of childhood AML may result from a prior myelodysplastic phase. About 2% to 3% of all cases of juvenile leukemia are associated with juvenile myelomonocytic leukemia.

Knowledge is Critical when Dealing with a Life-Altering Condition such as Myelodysplastic Syndromes

If you or a loved one has been diagnosed with myelodysplastic syndromes (MDS), it's critical to learn everything you possibly can about this condition so that you can make informed decisions about your treatment. That's why we created the Medifocus Guidebook on Myelodysplastic Syndromes, a comprehensive 145 page patient Guidebook that contains vital information about MDS that you won't find anywhere in a single source.

The Medifocus Guidebook on Myelodysplastic Syndromes starts out with a detailed overview of the condition and quickly imparts fundamentally important information about MDS, including:

  • The latest theories regarding the underlying causes of MDS.
  • The risk factors that can increase a person's chances for developing MDS.
  • The signs and symptoms that are associated with MDS.
  • How MDS is diagnosed based on factors such as signs/symptoms, patient history, physical examination, special blood tests, and chromosomal abnormalities.
  • A detailed overview of the major classification systems that are used by doctors to determine the extent or severity of the disease in patients with MDS, including:

    • The French-American-British (FAB) classification system
    • The World Health Organization (WHO) classification system
    • The International Prognostic Scoring System (IPSS)

Understanding the Standard Treatments... and the Treatment Options

Treatment of myelodysplastic syndromes (MDS) is individualized for each patient taking into consideration factors such as the severity of the low blood counts, the risk of progression to AML, other potential complications, and the patients age and overall health. The goals of treatment of myelodysplastic syndromes include:

  • Prevent and/or treat complications of MDS
  • Attempt to cure MDS, if possible
  • Maintain the highest possible quality of life
  • Prolong survival

Understanding the standard treatments - and the treatment options - is critical for successfully achieving the goals of treatment for MDS and is particularly important for enabling the patient to maintain a reasonably good quality of life and prolonging survival. As you read through the section of the Guidebook that focuses on the treatments for MDS, you will specifically learn about:

  • Intensive chemotherapy for patients with MDS with a class of drugs known as demethylating agents, including the side-effects associated with these medications.
  • The role of stem cell transplantation in the management of patients with MDS, including the risks, benefits, and complications associated with this procedure.
  • Supportive treatments that are commonly used to manage anemia (abnormally low red blood cell counts) and neutropenia (abnormally low white blood cell counts) in patients with MDS.
  • Recent advances in the management of MDS with drugs known as immunomodulatory agents, such as thalidomide and lenalidomide (Revlimid).
  • The treatment and management of MDS in infants and children.
  • The role of complementary and alternative therapies in the management of patients with MDS.
  • The prognosis (outlook) for people with MDS and important prognostic factors that have a significant impact in predicting the overall chances of recovery and survival.
  • Quality of life issues such as sleep disorders, fatigue, weight loss, and psychological stress that often confront people with MDS and tips for how to minimize their impact and better cope with these important issues.
  • Important questions to ask your doctor about MDS.

A "One-of-a-Kind" Reference Guidebook on Myelodysplastic Syndromes that Goes Way Beyond the Fundamentals

Since 1996, when Medifocus was founded, we've learned that many people with Myelodysplastic Syndromes are seeking more specific information that goes beyond the fundamentals, such as the causes, diagnosis, standard treatments, and treatment options. That's why we developed a "one-of-a-kind" reference Guidebook that goes way beyond the basics and also includes the following sections:

  • A Guide to Recent Medical Literature on Myelodysplastic Syndromes - This section of the Guidebook contains an extensive bibliography of over 100 references to recently published articles about Myelodysplastic Syndromes in authoritative, peer-reviewed medical journals with links to the absracts (summaries) of the articles. These articles represent the latest advances in the field and focus on cutting-edge research, new developments, and the lessons learned from recently published clinical trials involving patients with Myelodysplastic Syndromes. This is the same level of that is used by doctors who treat people with Myelodysplastic Syndromes to keep abreast of the latest developments and breakthroughs in this specialized field of medicine.

  • Centers of Research for Myelodysplastic Syndromes - We've compiled a unique directory of doctors, hospitals, medical centers, and research institutions with special interest and, in many cases, clinical expertise in managing people with Myelodysplastic Syndromes. The "Centers of Research" directory is a valuable resource for quickly identifying and locating leading medical authorities and medical institutions both within the United States and other countries who are considered to be at the forefront in clinical research and treatment of Myelodysplastic Syndromes. You'd have to spend days - or even weeks - attempting to compile your own list of doctors and medical centers but, with the "Centers of Research" directory, the information is already right at your fingertips. All you have to do is act on the information by selecting and contacting the experts or medical institutions listed in the directory by state and country.

  • Organizations and Support Groups for Myelodysplastic Syndromes - The Guidebook also includes a directory of organizations and support groups whose goal is to help people with Myelodysplastic Syndromes by providing access to information, resources, and services. Many of these organizations can answer your specific questions, enable you to "network" with other patients, and provide guidance in areas such as financial, social, or medical-legal issues. This valuable directory of organizations and support groups includes complete contact information, including phone numbers and E-mail addresses.

Look Inside the Guidebook

The Guidebook is a Value-Added Proposition that Comes with a Risk-Free Satisfaction Guarantee so that...You have Nothing to Lose and Everything to Gain

Still not sure if you'll benefit from the Medifocus Guidebook on Myelodysplastic Syndromes? Still not convinced that the information included in the Guidebook is worth the minimal cost? If that's the case, then please consider the following value-added proposition that comes standard with your purchase of the Guidebook:

  • Free Updates for One Year - With your initial purchase of the Guidebook, you also receive access to free updates for one-full year. The Guidebook is updated with new information every 4 to 6 months, so that you will be able to access the updated information several times during the course of a year for up to one full year after the date of your initial purchase.

  • Free Digest E-Mail Alerts - When you purchase the Guidebook, you will also automatically receive a free subscription to our monthly newsletter - the Medifocus Digest Alert for Myelodysplastic Syndromes. This is an expertly selected listing of the latest articles published in the medical literature about Myelodysplastic Syndromes with convenient links to the abstracts of the articles that focus on cutting-edge research, clinical trials, and the latest treatment advances. The Medifocus Digest Alert for Myelodysplastic Syndromes is automatically delivered straight to your "inbox" monthly and is a valuable resource for keeping up with the latest developments in Myelodysplastic Syndromes almost as soon as the new information is published in the medical literature.

  • 20% Discount - For a limited time, you can purchase the Medifocus Guidebook on Myelodysplastic Syndromes at a special 20% discount off the regular list price. Your 20% discount will automatically be applied when you go to "Checkout".

  • Risk-Free Satisfaction Guarantee - Your purchase comes with our RISK-FREE satisfaction guarantee. If, for whatever reason, you are not totally satisfied with the content of your Guidebook, simply contact us within 30-days of your purchase for a prompt, full refund. We are so confident that you will be satisfied with your Guidebook that we offer this RISK-FREE satisfaction guarantee unconditionally - no questions and no hassles.

Order Your Copy of the Medifocus Guidebook on Myelodysplastic Syndromes Today!

The Medifocus Guidebook on Myelodysplastic Syndromes (145 pages; last updated July 22, 2016) is available in the following two convenient formats:

  • PRINTED GUIDEBOOK - Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.):

    • Regular List Price = $36.95
    • Less 25% Discount = - $9.25
    • Your Discounted Price = $27.70 (excluding shipping & handling)
Order the Printed Guidebook

  • DIGITAL GUIDEBOOK - Available for immediate download as a PDF document:

    • Regular List Price = $27.95
    • Less 25% Discount = - $7.00
    • Your Discounted Price = $20.95
Order the Digital Guidebook

To Place Your Order by Telephone, please call us:
  • Within the United States (toll free): 1-800-965-3002
  • Outside the United States: 1-301-649-9300
   
Get the Medifocus Guidebook on Myelodysplastic Syndromes...

at a Special 25% HOLIDAY Discount
(Offer valid through December 31, 2016)

Medifocus Guidebook on Myelodysplastic Syndromes


Updated: July 22, 2016
145 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee
FREE Guidebook Preview

Order the Guidebook at a
Special 25% HOLIDAY Discount

The Medifocus Guidebook on Myelodysplastic Syndromes is available in the following two convenient formats: Printed and Digital.

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.):

Discount Coupon Code

MS72172145

(automatically applied at checkout)

Coupon Expires: January 10, 2017


  • Regular List Price = $36.95
  • Less 25% Discount = - $9.25
  • Discounted Price = $27.70 (excluding shipping & handling)
Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document:

Discount Coupon Code

MS72172145

(automatically applied at checkout)

Coupon Expires: January 10, 2017


  • Regular List Price = $27.95
  • Less 25% Discount = - $7.00
  • Discounted Price = $20.95
Order the Digital Guidebook




Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 25% discount when you order your Guidebook by phone.

To receive your 25% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

MS72172145

Coupon Expires: January 10, 2017




FREE NEWSLETTER

Get the Medifocus Digest Alert on Myelodysplastic Syndromes. Yours FREE!    View Sample

Enter your email address:

I have read and agreed to the Medifocus Privacy Policy.



What Our Customers Are Saying...

"I purchased the MediFocus Guidebook on Myelodysplastic Syndromes to help my father understand the disease that he has. Doctors in France do not communicate very well the various treatment options neither do they tell you about the prognosis with enough clarity and confidence. We live in France and we believe there is no equivalent in Europe to the service you offer. We have read the Guidebook attentively and have learned a great deal about this condition. The wording is simple enough to be understandable even for non-native English speakers. It was money well spent!"
P.M.
Saint Ismier, France


"Your MediFocus Guidebook on Myelodysplastic Syndromes has been a valuable companion in providing wise counsel to a beleaguered soul. Many times I was comforted by knowing that I could have my questions answered correctly and completely by using your Guidebook. I wouldn't be without it for anything. Thank you again and again."
S.M.
Rockville, Maryland


"Your Medifocus Guidebook on Myelodysplastic Syndromes has been extremely valuable to me in understanding the complicated disease that afflicts me. It can be very depressing but to understand it intellectually can be very calming and heartening. Fear of the unknown is most devastating and your Guidebook provides the facts in an understandable way without 'watering-down' the science. Thank you for your outstanding publication."
N.M.
Los Angeles, California


 
Medifocus Guidebook on Myelodysplastic Syndromes

Order the Guidebook
 

 

Privacy Policy   © 1996-2016 Medifocus.com, Inc. or its affiliates     Page Updated on: July 22, 2016